Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q1 2026 Earnings Presentation
20 slides from Aurora Cannabis's earnings presentation, Aug 6, 2025
Slide 1: Investor Presentation FY26 Q1
Investor Presentation FY26 Q1 June 2025
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Diversified Global Business Model
Diversified Global Business Model Focus on Defensive, Stable, High Margin Segments International Canadian Medical Plant Propagation Canadian Consumer Science & Innovation Medical #1 Canadian Medical share Record net revenue in Q1 FY Ability to deliver products that Delivering a continuous stream by
Slide 4: Leading Global Cannabis Platform
Leading Global Cannabis Platform • Global medical cannabis net revenue(1) reached $64.8m in Q1, up 37% • Supplied from highly efficient, high quality Canadian EU and TGA GMP compared to the prior year period. manufacturing facilities – a clear competitive advantage in the highly regulated medical ma
Slide 5: Leadership in Key Global Cannabis Markets
Leadership in Key Global Cannabis Markets UNITED KINGDOM: ~68m population POLAND: ~40m population • Aurora markets the highest THC product in the market with Farm Gas. • Strong market position through relationships with key distributors and Farm Gas was the #1 product by volumes sales to pharmacies
Slide 6: European Medical Leadership
European Medical Leadership Aurora is a leader in the German, Polish and UK markets due to a consistent supply of high-quality and innovative EU GMP cannabis products. Consistent Revenue Stream and Margin Leader Aurora Product Range • Aurora Europe was the #2 supplier of medical cannabis to each cor
Slide 7: FY26 Q1 Product Launches: Europe
FY26 Q1 Product Launches: Europe Aurora Europe continues to lead with innovative, high-quality product launches. In Q1, we launched two flower products including Farm Gas which is now highest THC product available in Poland. In the UK, we entered the emerging inhalable extract market with two offeri
Slide 8: Australia & New Zealand Market Leadership
Australia & New Zealand Market Leadership Aurora continues to expand its medical product portfolio through our wholly-owned subsidiary MedReleaf Australia, the # 2 player in the market, to meet the growing needs of the patients in Australia and New Zealand. Consistent Revenue Stream, Margin Leader a
Slide 9: FY26 Product Launches: Australia & New Zealand
FY26 Product Launches: Australia & New Zealand In Q1, four new SKUs launched in Australia, spanning a range of potencies and addressing diverse patient needs. Highlights included the introduction of a new 22% potency band in IndiMed, a larger 15g format of IndiMed 26%, and the debut of our newest br
Slide 10: Canadian Medical Leadership
Canadian Medical Leadership Aurora is leading the market with four owned medical cannabis brands and a wide variety of marketplace offerings. Value Core Premium Super Premium “The Medical Grade Standard” “A Natural Part of Your Recovery” “Your Ally in Medical Cannabis” “Better Days Ahead” Consistent
Slide 11: Canadian Medical Leadership
Canadian Medical Leadership Aurora’s leading position is supported by consistent revenue, superior patient experience & a diverse portfolio. Consistent Revenue Stream and Best in Class Patient Breadth and Depth of Margin Leader Experience Product Portfolio • #1 Canadian Medical Share by revenue; • P
Slide 12: Market Leading Patient Focused Selection
Market Leading Patient Focused Selection Dried Flower & Pre-rolls Oils & Lozenges Edibles & Beverages Vapes & Concentrates • MedReleaf Kaleidum • XK CBD 2000 Spray • Pearls Blue Razzleberry 3:1 CBG:THC • Back Forty Watermelon Ice AIO Vape • MedReleaf United Victory • XK Indica 500:500 THC CBD Spray
Slide 13: A Compelling Portfolio of Adult Recreational Brands
A Compelling Portfolio of Adult Recreational Brands Core Alternative Premium Super Premium Maximum Flavour, Maximum Potency, High-THC edibles for the Proprietary genetics with unique aromas Exceptional true-to-cultivar, craft offerings. Brand Promise Maximum Value modern-day consumer in a range of s
Slide 14: Sales and Marketing Support
Sales and Marketing Support Ongoing national campaign focused on maximizing brand and product Innovation will be communicated to retailers via national e-mail and in- awareness, further enhancing purchase consideration for Tasty's Vapes. store pitches. They will be supported by a full suite of digit
Slide 15: Plant Propagation Overview
Plant Propagation Overview Aurora holds a controlling interest in Bevo Farms, an industry leader in plant propagation and one of the largest suppliers of propagated vegetables and ornamental plants in North America. • Bevo contributed record revenues of ~$23.9 million in Q1 up 4% compared to the pri
Slide 16: Science & Innovation Program
Science & Innovation Program A state-of-the-art breeding facility in Vancouver Island’s Comox Valley: • Built specifically to develop the next big cultivars: high potency, with excellent bud structure and density, highly aromatic and expressing unique terpene profiles sought by patients and consumer
Slide 17: Key Takeaways
Key Takeaways Opening the Achievement of Robust and Enabled by World to Financial $ Differentiated Science Cannabis Milestones Balance Sheet Largest global medical cannabis Achieved positive free cash flow1 of Completed final repayment of $465 Leading cannabis plant genetic work company in n
Slide 18: Senior Management Team
Senior Management Team Miguel Martin Executive Chairman & CEO Miguel’s career spans nearly 30 years in consumer- packaged goods, covering various regulated categories and fast-moving markets. Miguel is the former CEO & President of Reliva. Simona King Nathalie Clark Alex Miller Chief Financial Offic
Slide 19: Board of Directors
Board of Directors Miguel Martin Executive Chairman & CEO Miguel’s career spans nearly 30 years in consumer- packaged goods, covering various regulated categories and fast-moving markets. Miguel is the former CEO & President of Reliva. Norma Beauchamp Theresa Firestone Ronald Funk Director Director
Slide 20: Investor Presentation
Investor Presentation Email: aurora@icrinc.com Website: auroramj.com/investors